INTRODUCTION
============

Chondevrepocytes are the cellular component of cartilage, responsible for generating and maintaining its extracellular environment ([@R24]). Cartilage has multiple functions such as providing cushion on the articular surfaces of joints, providing a template for the formation of endochondevrepal bone, and contributing to fracture repair ([@R33]; [@R16]). However, cartilage defects have only a limited intrinsic healing capacity ([@R12]). Thus, the cell-based regeneration of (osteo) chondevrepal defects presents a major challenge ([@R29]; [@R11]; [@R13]).

Human mesenchymal stem cells (MSCs) with multiple differentiation potentials are a promising alternative cell source for cartilage regeneration ([@R8]; [@R6]). The differentiation of mesenchymal cells into chondevrepocytes takes place along a multistep pathway ([@R36]). The steps in this pathway include the recruitment of mesenchymal chondevrepoprogenitor cells, the subsequent condensation of these mesenchymal cells, followed by the frank differentiation of the condensed mesenchymal cells into chondevrepocytes. Cells within these condensations commit to the chondevrepogenic lineage, acquire spherical cell morphology and induce expression of the essential chondevrepogenic transcription factor Sox9. Sox 5 and Sox6 cooperate with Sox9 to control chondevrepogenesis and are themselves under the transcriptional control of Sox9 ([@R9]; [@R18]). Together, these transcription factors activate transcription of the major chondevrepogenic matrix genes, collagen type II (COL II) and aggrecan. Furthermore, increased glycosaminoglycan (GAG) content is another marker of the chondevrepogenic extracellular matrix (ECM) ([@R4]; [@R6]). In the growth plate of skeletal elements that undergo endochondevrepal ossification, several layers of chondevrepocytes then become flattened and the cells proliferate mainly unidirectionally ([@R36]; [@R39]). These cells then stop proliferating, change their genetic program and become hypertropic ([@R29]). The ECM of the most advanced hypertrophic chondevrepocytes becomes mineralized before these cells undergo apoptosis and are replaced by the cells that will become the constituent cells of bones ([@R11]).

Chondevrepogenic induction *in vitro* stands as a special culture system achieved by forcing aggregation for mesenchymal cells or chondevrepoprogenitor cells to generate a 'micromass' or 'pellet' culture and treating this with transforming growth factor-*β* (TGF-*β*) superfamily members ([@R5]; [@R37]). TGF-*β* promotes cartilage-specific gene expression through intracellular signaling cascades involving SMAD proteins, and the mitogen activated protein (MAP) kinases ([@R3]; [@R21]; [@R2]; [@R12]). The therapeutic potential of MSCs for cartilage repair is clear ([@R8]; [@R29]; [@R6]). However, the requirements and conditions for effective induction of chondevrepogenesis in MSCs and for the production of a stable cartilaginous tissue by these cells are far from being understood. Thus, gaining a better understanding of signaling pathways that regulate these conditions is essential.

A C2 domain is a protein structure domain involved in targeting protein to cell membrane. The C2 domain is found in many cellular proteins involved in signal transduction or membrane trafficking. C2 domains are unique among membrane targeting domains in that they show wide range of lipid selectivity for the major components of cell membranes, including phosphatidylserine and phosphatidylcholine ([@R10]). This C2 domain is about 116 amino-acid residues and is located between the two copies of the C1 domain in Protein Kinase C (PKC) and the protein kinase catalytic domain. Regions with significant homology to the C2 domain have been found in many proteins ([@R7]).

Although the function of C2 domain in chondevrepogenesis is unknown, C2 domain may play a role in signaling pathways that regulate chondevrepocyte differentiation. The present study was undertaken to reveal whether the C2 domain is involved in signaling processes of chondevrepogenesis.

MATERIALS AND METHODS
=====================

1.. Cell culture
----------------

Human MSCs were purchased from Lonza (Walkersville, MD). The cells were expanded in low-glucose DMEM containing 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 μg/ml) in a 5% CO~2~ incubator at 37°C. Normal human fibroblast (NHFB) were obtained from Chungnam National University and cultured in DMEM containing 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 μg/ml). All culture media and supplements were obtained from Gibco (Carlsbad, CA).

2.. Screening of hMSC differentiation-related C2-domains
--------------------------------------------------------

The C2 domain library containing 145 kinds was manufactured using the gateway adenovirus system ([@R27]; [@R28]). That adenovirus library was then infected to hMSCs individually. Final candidates were classified and selected by the degree of their effects on morphological changes.

3.. *In vitro* chondevrepogenic induction
-----------------------------------------

Chondevrepogenic differentiation of the hMSCs was initiated in a micromass culture system ([@R41]; [@R37]). Cells were dissociated for single-cell suspension stating at density of 2.0×10^7^ cells/ml, and a 10-μl devrepop of this cell suspension was placed in the center of a culture dish. The cells were allowed to adhere at 37°C for 2 h, followed by the addition of chondevrepogenic medium (high-glucose DMEM containing 100 nM dexamethasone (Sigma, St. Louis, MO), 50 μg/ml ascorbic acid-2-phosphate (Sigma), 1% penicillin streptomycin, and ITS-Premix (6.25 μg/ml insulin, 6.25 μg/ml transferrin, 6.25 μg/ml selenous acid, 5.33 μg/ml linoleic acid and 1.25 mg/ml bivine serum albumin; BD Biosciences, Bedford, MA) with or without 10 ng/ml TGF-*β*3 (R&D systems, Minneapolis, MN). After 24 h, the cell devrepoplets coalesced and became spherical. The medium was changed every 2 days.

4.. Construction of recombinant adenovirus and Adv-PKCη-C2-domain transduced culture
------------------------------------------------------------------------------------

Human MSCs at 80% confluence were transfected with 100 MOI of Adv-GFP or Adv- PKC*η*-C2 domain for 2 h, and media were changed with fresh DMEM + 10% FBS. Seven day after infection, cell morphology was examined using an inverted fluorescence microscope (IX81, Olympus, Japan) coupled to a CCD camera (Olympus DP71). For micromass culture, transfected cells were seeded 24 h after infection.

5.. Reverse transcription-PCR (RT-PCR)
--------------------------------------

Total RNA was isolated with the TRIzol reagent (Invitrogen, Carlsbad, CA) and 1 μg RNA was reverse transcribed for synthesis of first cDNA strand. Synthesized cDNA was used as a template in PCR using *Taq* polymerase (Takara, Japan) with gene specific primers (Table [2](#T2){ref-type="table"}). PCR products were separated on 1.5 % agarose gel and visualized by ethidium bromide staining.

###### 

List of primers used for PCR

  --
  --

6.. Western blot analysis
-------------------------

Cells were lysed in lysis buffer containing 50 mM Tris-Cl (pH 8.0), 150 mM NaCl, 1% NP-40, 0.02% sodium azide, 0.5% sodium deoxycholate, 0.1% SDS, 100 μg/ml phenylmethylsulphonyl fluoride, 0.5 μg/ml leupeptin, 1 μg/ml aprotinin. After a brief sonication, the lysates were clarified by centrifugation at 12,000×g for 30 min at 4°C. Protein concentrations were determined with a BCA protein assay kit (Pierce Biotechnology, Inc., Rockford, IL). Equal amounts of protein were loaded on 10% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane. Membranes were blocked with 5% skim milk in TBS containing 0.1% Tween-20 for 2 h at room temperature and incubated with the appropriate primary and secondary antibodies. Labeled proteins were detected using ECL Western blotting detection reagents (Amersham Biosciences, Piscataway, NJ). Antibodies used were: COL1A1, COL2A1, and PKC*η* (Santa Cruz Biotechnology, Santa Cruz, CA), α-tubulin (Sigma).

7.. Histology
-------------

Micromasses were fixed in 4% paraformaldehyde for 3 h, then dehydevrepated with ethanol, cleared with xylene and embedded in paraffin. Sections at 5 μm were cut and mounted on glass slides. Sections were deparaffinized and hydevrepated to distilled water, followed by staining with hematoxylin and eosin or Alcian blue and fast red. Finally sections were brought to xylene solution with several dehydevrepation steps and mounted.

8.. Alcian blue staining
------------------------

Chondevrepogenic differentiation was measured by Alcian blue staining of sulfated cartilage glycosaminoglycans. Cells were fixed in 4% paraformaldehyde for 10 min and then incubated with 0.1% HCl-Alcian blue for 1 h. Excess stain was washed off with distilled water, and pictures were taken. To evaluate staining intensity, Alcian-blue-bound sulfated glycosaminoglycans were extracted with 6 M guanidine-HCl, and quantified by measuring the absorbance of the extracts at 620 nm.

9.. Lectin peanut agglutinin (PNA) staining
-------------------------------------------

Binding of peanut agglutinin (PNA) was used as a specific marker for precartilage condensation. Cells were fixed in 4% paraformaldehyde for 10 min and then incubated with 100 μg/ml FITC conjugated PNA (Sigma) for 1 h. PNA binding was visualized using FITC fluorescence.

10.. Statistical analysis
-------------------------

The data were presented as the mean ± SE. Student's t test was used for all comparisons. A *P* value of \<0.05 was considered statistically significant.

RESULTS
=======

1.. Screening of hMSC differentiation-related C2-domains
--------------------------------------------------------

To screen whether C2 domain can differentiate hMSCs to chondevrepocyte, 145 C2-domain containing adenovirus were infected to hMSCs individually. Seven days after transfection, primary candidates were selected by the degree of their effects on morphological changes (Fig. [1](#F1){ref-type="fig"}). As shown in Table [1](#T1){ref-type="table"}, 12 C2 domains were selected for further study.

![**Morphological change of hMSCs 7 days after 145 C2 domain containing adenovirus library transfection.** The origin of 12 red boxed C2 domain was listed in Table [1](#T1){ref-type="table"}. Human MSCs at 80% confluence were transfected with 100 MOI of Adv-GFP or Adv-C2 domain for 2 h, and media were changed with fresh DMEM+10% FBS. Seven day after infection, cell morphology was examined using an inverted fluorescence microscope (IX81, Olympus, Japan) coupled to a CCD camera (Olympus DP71).](devrep-17-299-F1){#F1}

###### 

List of selected C2-domain containing genes

  --
  --

2.. TGF-*β*3 induced chondevrepogenesis of hMSCs in a micromass culture
-----------------------------------------------------------------------

To induce chondevrepogenesis of hMSCs, micromasses were cultured in chondevrepogenic medium and stimulated with TGF-*β*3 (10 ng/ml). In most MSC chondevrepogenesis studies, differentiation is induced under serum-free media conditions in the presence of TGF-*β*3, a known inhibitor of matrix mineralization ([@R13]). In this micromass culture system, cellular condensation occurred at 1 day after TGF-*β*3 treatment and a spherical formation was confirmed at 2 days after (Fig. [2A](#F2){ref-type="fig"}). Consistent with this observation, the degree of precartilage condensation as assessed by PNA binding was significantly increased in TGF-*β*3 treated micromass (Fig. [2B](#F2){ref-type="fig"}). After 2 days, micromass cultures were stained with Alcian blue to visualize GAG content (Fig. [2C](#F2){ref-type="fig"}).

![**Chondevrepogenic differentiation of hMSCs in a micromass culture.** (A) Pictures of differentiating hMSC aggregates from micromass culture. Bar: 500 μm. (B) PNA staining of cultures treated with TGF-β3 demonstrates a change in cellular condensation. Bar: 500 μm. (C) MSCs were cultured as micromass and treated with TGF-β3 (10 ng/ml). Cultures were stained with Alcian blue after two days.](devrep-17-299-F2){#F2}

3.. PKC*η* gene expression is increased during chondevrepogenesis
-----------------------------------------------------------------

To evaluate which selected gene is closely related to the chondevrepogenesis of hMSC, gene expressions were analyzed by RT-PCR. Among 12 C2 domains, domain of PKCη showed similar expression pattern to COL II during TGF-*β*3 treatment (Fig. [3](#F3){ref-type="fig"}). The gene expression of Sox9, COL II, aggrecan, and PKCη strongly increased by day 2 of culture with TGF-β3, and expression remained until day 7 (Fig. [4](#F4){ref-type="fig"}). The levels of COL II and PKCη protein were also increased by TGF-β3 (Fig. [5](#F5){ref-type="fig"}). COL I, which signifies inadequate differentiation, did not show a significant increase in protein level (Fig. [5](#F5){ref-type="fig"}).

![**C2 domain containing gene expressions during chondevrepogenic differentiation.** During chondevrepogenic differentiation of hMSC, C2 domain containing gene expressions were changed by TGF-β3.](devrep-17-299-F3){#F3}

![**PKCη gene expression during chondevrepogenic differentiation.** Addition of TGF-β3 led to rapid expression of PKCη, which increased at day 2, and was sustained until day 7.](devrep-17-299-F4){#F4}

![**PKCη protein expression during chondevrepogenic differentiation.** Chondevrepogenesis was initiated by micromass culture, supplemented with TGF-β3 (10 ng/ml), the COL II, COL I, and PKCη expression was determined by Western blot analysis at day 3.](devrep-17-299-F5){#F5}

4.. PKC*η*-C2 domain induces chondevrepogenic differentiation in hMSCs
----------------------------------------------------------------------

The C2 domain of PKC*η* is thought not to affect substrate-specificity of the kinase but instead aid in its localization to membranous systems ([@R22]). PKC*η* overexpression induces G1 arrest and differentiation in keratinocytes. In addition to epithelial cells, recent studies revealed that PKC*η* acts as a key regulator in early B-cell development ([@R17]). To test whether PKC*η*-C2 domain functions in chondevrepogenesis, hMSCs were infected with Adv-vec or Adv-PKC*η*-C2 domain and cultured in monolayer for 7 days. Although high-density cell culture environment is pivotal for the chondevrepogenic differentatiation of hMSCs, PKC*η*-C2 domain induced morphological change of hMSCs from a characteristic fibroblast-like morphology to a large round shape (Fig. [6A](#F6){ref-type="fig"}). In addition PKC*η*-C2 domain markedly induces chondevrepocyte matrix formation after 7 days of monolayer culture, as shown by Alcian blue staining of the cartilaginous matrix (Fig. [6B](#F6){ref-type="fig"}). Chondevrepogenic effect of PKC*η*-C2 domain was further confirmed in adenovirus infected MSCs micromass model by assessing spherical size and chondevrepocyte matrix formation (Fig. [6C](#F6){ref-type="fig"}). The level of a chondevrepogenic protein, COL II was also increased by PKC*η*-C2 domain (Fig. [6D](#F6){ref-type="fig"}). PKC*η*-C2 domain also increased chondevrepogenic differentiation in micromass model.

![**Effect of PKCη-C2 domain on differentiation of hMSCs.** (A) In a monolayer culture, Adv-PKCη-C2 domain infection led to morphological change at day 7 after transfection. Transfected cells were confirmed by GFP expression. Bar: 20 μm. (B) Chondevrepogenesis of hMSCs after PKCη-C2 domain infection. Transfected cells were cultured for 7 days in monolayer, chondevrepogenesis was quantified by measuring the absorbance of bound Alcian blue at 620 nm. (C) Effect of PKCη-C2 domain on chondevrepogenic differentiation. After PKCη-C2 domain transfection, chondevrepogenesis was initiated by micromass culture. Chondevrepogenesis was measured by Alcian blue staining at 4 days after induction. Bar: 500 μm. (D) Effect of PKCη-C2 domain on COL II expression. Transfected cells were cultured for 7 days in monolayer, the COL II, COL I, and PKCη expression was determined by Western blot analysis.](devrep-17-299-F6){#F6}

5.. PKC*η*-C2 domain induces collagen type II expression
--------------------------------------------------------

As shown in Fig. [6D](#F6){ref-type="fig"}, COL II gene expression was affected by PKCη-C2 domain. To investigate further the roles of PKCη-C2 domain in COL II gene expression, PKCη-C2 domain was overexpressed in NHFB cells. The COL II protein expression was increased by PKCη-C2 domain and this effect was more evident according to time (Fig. [7](#F7){ref-type="fig"}).

![**Effect of PKCη-C2 domain on NHFB.** In a monolayer culture, Adv-PKCη-C2 domain transfection increased COL II expression.](devrep-17-299-F7){#F7}

DISCUSSION
==========

Natural chondevrepogenesis is a well-coordinated developmental differentiation program that leads to permanent articular cartilage in the joint or to transient cartilage during endochondevrepal bone formation ([@R24]; [@R36]; [@R8]; [@R6]). Generation of stable hyaline cartilage from MSCs is currently still a challenge. Although chondevrepogenesis and cartilage formation are achieved, it eventually leads to terminal differentiation of chondevrepocytes instead of the production of stable hyaline cartilage ([@R29]; [@R13]). Further, the tissue-engineered cartilage construct is not stable when it is implanted *in vivo* but mineralizes ([@R30]). A better knowledge of mechanisms determining chondevrepocyte differentiation and terminal differentiation is therefore crucial to control the chondevrepogenic differentiation of MSCs. In the present study, it was demonstrated that PKC*η*-C2 domain regulates COL II gene expression and TGF-*β*3-induced chondevrepogenic differentiation.

Chondevrepogenic differentiation was achieved following the direct chondevrepogenic differentiation *in vitro* micromass protocol ([@R38]; [@R39]; [@R14]). The production of specific chondevrepogenic markers were measured at 2, 4, 7, and 14 days of culture in chondevrepogenic medium. The quantitative RT-PCR analysis measured the expression of COL I, COL II, and COL X in the spheroid formed during the chondevrepogenic process. Because spheroids first appear in this study after 2 days in culture in differentiation medium, the measurement of the expression of COL I, COL II, and COL X in the spheroids was began at 2 days. The expression of COL I, COL II, and COL X was found as early as 2 days of chondevrepogenic differentiation. These results are coincident with previous reports ([@R38]; [@R39]; [@R14]). COL II and COL X both increased their expression over time.

It is known that during the differentiation process of MSCs, one or several intracellular chemical cascades are modified influencing the ultimate commitment of the cell ([@R9]). However, it remains unclear how each individual pathway affects the differentiation program of the cells and how manipulation of these pathways could lead to more efficient differentiation protocols.

PKC is a family of related protein kinase, which includes at least 10 different isoforms in mammalian cells ([@R25]). They play important roles in the transduction of signals coupled to receptor-mediated hydevrepolysis of membrane phospholipids. The mammalian isoenzymes can be classified into three groups according to their structure and cofactor regulation. The first group includes the classical isoforms (*α*, *β*I, *β*II, and *γ*), which function is regulated by calcium, acidic phospholipids, and diacylglycerol. The second group corresponds to the novel PKCs (*δ*, *ε*, *η*, and *θ*), which are activated by acidic phospholipids and diacylglycerol in a calcium-independent manner. These two groups contain in their regulatory regions both conserved C1 domains responsible for sensing diacylglycerol, and C2 domains responsible for sensing Ca^2+^ and/or acidic phospholipids at different subcellular compartments. The third group comprises the atypical PKC isoforms (*ξ*, *τ* /*λ*), which are not regulated by diacylglycerol or by calcium ([@R26]; [@R31]).

The C2 domains of classical and novel PKC play a important role in decoding signals, which trigger the translocation of these enzymes to the plasma membrane and/or other membrane ([@R22]; Corbalán-García & Gómez-Fernández, 2010). Although the C2 domains of novel PKCs were supposed to play only a secondary role with respect to the C1 domain in the activation process of these enzymes, new insights reveal that these C2 domains may also receive regulatory inputs and play an important role in the localization and activation of these enzymes ([@R26]; [@R25]; [@R7]; [@R31]).

The novel PKC*η* isoform has a unique tissue distribution and is primarily expressed in epithelial tissue and cells undergoing high turnover ([@R17]). It is implicated in diverse cellular functions, including a role in terminal differentiation, proliferation, and secretion ([@R35]; [@R19]; [@R1]; [@R20]). Recent studies suggest that PKC*η* has a special role in response to stress and regulation of apoptosis ([@R32]). However the function of the PKC*η* in chondevrepogenesis is not well understood.

In this study, PKC*η* gene expression increased during TGF-*β*3-induced chondevrepogenic differentiation. In addition, PKC*η*-C2 domain induced the gene expression of COL II in monolyer and micromass culture. The molecular mechanisms activated in MSCs, leading to the increased expression of PKC*η*, are currently not understood. Chondevrepogenesis might be a product of orchestration of related genes as shown in the TGF-*β*3/bone morphogenic protein 2-induced chondevrepogenesis of MSC ([@R34]). However, introduction of one protein into human amniotic fluid-derived stem cells changed the pluripotency ([@R15]). Furthermore, PKC*δ* gene silencing with shRNA caused a severe reduction in cartilage formation ([@R23]). Although it seems not to enough, only PKC*η*-C2 domain can induce chondevrepogenesis via influencing the Ca^2+^-related signaling.

In summary, the present study demonstrates interaction between PKC*η*-C2 domain and the COL II gene expression, providing new insights into the possible links of PKC*η* to the chondevrepogenesis. Further studies are needed for the elucidation of the molecular mechanisms involved.
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